Cargando…
FORMULATION AND EVALUATION OF ENTERIC COATED TABLETS OF PROTON PUMP INHIBITOR
The present study was an attempt to formulate and evaluate enteric coated tablets for esomeprazole magnesium trihydrate. Different core tablets were prepared and formulation (F-1) was selected for further enteric coating, based on the disintegration time. Seal coating was applied to achieve 3% weigh...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979213/ https://www.ncbi.nlm.nih.gov/pubmed/24825991 |
_version_ | 1782310711068721152 |
---|---|
author | Nair, Anroop B Gupta, Rachna Kumria, Rachna Jacob, Shery Attimarad, Mahesh |
author_facet | Nair, Anroop B Gupta, Rachna Kumria, Rachna Jacob, Shery Attimarad, Mahesh |
author_sort | Nair, Anroop B |
collection | PubMed |
description | The present study was an attempt to formulate and evaluate enteric coated tablets for esomeprazole magnesium trihydrate. Different core tablets were prepared and formulation (F-1) was selected for further enteric coating, based on the disintegration time. Seal coating was applied to achieve 3% weight gain using opadry®. Enteric coating was carried out using different polymers like Eudragit L-30 D-55, hydroxy propyl methylcellulose phthalate, cellulose acetate phthalate and Acryl-EZE® to achieve 5% weight gain. Disintegration studies showed that the formulations failed in 0.1 N HCl media. Hence the quantity of enteric coating was increased to 8% w/w. In vitro analysis of the developed tablets was carried out. Results from disintegration time and dissolution rate studies indicate that all the esomeprazole enteric tablets prepared possess good integrity, desirable for enteric coated tablets. Among the polymers studied, the methacrylic polymers exhibited better dissolution rate than the cellulose polymers. Stability studies indicate that the prepared formulations were stable for a period of three months. This study concluded that enteric coated tablets of esomeprazole can be prepared using any of the enteric coating polymer studied using a minimal weight gain of 8%. |
format | Online Article Text |
id | pubmed-3979213 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-39792132014-05-13 FORMULATION AND EVALUATION OF ENTERIC COATED TABLETS OF PROTON PUMP INHIBITOR Nair, Anroop B Gupta, Rachna Kumria, Rachna Jacob, Shery Attimarad, Mahesh J Basic Clin Pharm Original Article The present study was an attempt to formulate and evaluate enteric coated tablets for esomeprazole magnesium trihydrate. Different core tablets were prepared and formulation (F-1) was selected for further enteric coating, based on the disintegration time. Seal coating was applied to achieve 3% weight gain using opadry®. Enteric coating was carried out using different polymers like Eudragit L-30 D-55, hydroxy propyl methylcellulose phthalate, cellulose acetate phthalate and Acryl-EZE® to achieve 5% weight gain. Disintegration studies showed that the formulations failed in 0.1 N HCl media. Hence the quantity of enteric coating was increased to 8% w/w. In vitro analysis of the developed tablets was carried out. Results from disintegration time and dissolution rate studies indicate that all the esomeprazole enteric tablets prepared possess good integrity, desirable for enteric coated tablets. Among the polymers studied, the methacrylic polymers exhibited better dissolution rate than the cellulose polymers. Stability studies indicate that the prepared formulations were stable for a period of three months. This study concluded that enteric coated tablets of esomeprazole can be prepared using any of the enteric coating polymer studied using a minimal weight gain of 8%. Medknow Publications & Media Pvt Ltd 2010-09 2010-11-15 /pmc/articles/PMC3979213/ /pubmed/24825991 Text en Copyright: © Journal of Basic and Clinical Pharmacy http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Nair, Anroop B Gupta, Rachna Kumria, Rachna Jacob, Shery Attimarad, Mahesh FORMULATION AND EVALUATION OF ENTERIC COATED TABLETS OF PROTON PUMP INHIBITOR |
title | FORMULATION AND EVALUATION OF ENTERIC COATED TABLETS OF PROTON PUMP INHIBITOR |
title_full | FORMULATION AND EVALUATION OF ENTERIC COATED TABLETS OF PROTON PUMP INHIBITOR |
title_fullStr | FORMULATION AND EVALUATION OF ENTERIC COATED TABLETS OF PROTON PUMP INHIBITOR |
title_full_unstemmed | FORMULATION AND EVALUATION OF ENTERIC COATED TABLETS OF PROTON PUMP INHIBITOR |
title_short | FORMULATION AND EVALUATION OF ENTERIC COATED TABLETS OF PROTON PUMP INHIBITOR |
title_sort | formulation and evaluation of enteric coated tablets of proton pump inhibitor |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979213/ https://www.ncbi.nlm.nih.gov/pubmed/24825991 |
work_keys_str_mv | AT nairanroopb formulationandevaluationofentericcoatedtabletsofprotonpumpinhibitor AT guptarachna formulationandevaluationofentericcoatedtabletsofprotonpumpinhibitor AT kumriarachna formulationandevaluationofentericcoatedtabletsofprotonpumpinhibitor AT jacobshery formulationandevaluationofentericcoatedtabletsofprotonpumpinhibitor AT attimaradmahesh formulationandevaluationofentericcoatedtabletsofprotonpumpinhibitor |